Prosecution Insights
Last updated: May 29, 2026

Examiner: GOUGH, TIFFANY MAUREEN

Tech Center 1600 • Art Units: 1651 1657

This examiner grants 31% of resolved cases

Performance Statistics

31.2%
Allow Rate
-28.8% vs TC avg
550
Total Applications
+48.3%
Interview Lift
1657
Avg Prosecution Days
Based on 513 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
5.6%
§102 Novelty
65.6%
§103 Obviousness
3.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17056446 SPERM FERTILITY CAPACITY TEST AND SPERM DECAPACITATING SUPPLEMENT Final Rejection THE CURATORS OF THE UNIVERSITY OF MISSOURI
18220864 COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
16310981 Method and Composition for Reducing Pathogens in Rendered Food Products Using Lactic Acid Bacteria Non-Final OA Texas Tech University System
17995869 Biological Indicator with Test Microorganisms Enveloped by Wax Composition Final Rejection Solventum Intellectual Properties Company
18800472 A METHOD AND AN APPARATUS FOR TREATING PLANT BASED RAW MATERIAL WITH AN ENZYMATIC HYDROLYSIS Non-Final OA UPM-KYMMENE CORPORATION
17796018 BLOOD-BRAIN-BARRIER SYSTEMS Final Rejection B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
17310295 LACTOCOCCUS LACTIS STRAINS FOR THE PREVENTION AND/OR THE TREATMENT OF VISCERAL PAIN Final Rejection Universite Toulouse III - Paul Sabatier
17431997 NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR Non-Final OA Merz Pharma GmbH & Co. KGaA
17789045 LACTIC ACID BACTERIUM FERMENTATION PROMOTER Final Rejection MEIJI CO., LTD.
17837142 QUANTIFICATION METHOD OF VITAMIN D DERIVATIVE, ENZYME FOR QUANTIFICATION, COMPOSITION FOR QUANTIFICATION, KIT FOR QUANTIFICATION, ELECTRODE, SENSOR CHIP, AND SENSOR Final Rejection KIKKOMAN CORPORATION
18098422 IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS Final Rejection Instrumentation Laboratory Company
18070401 FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE Non-Final OA KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
18285088 PROCESS FOR BIOCONJUGATE PRODUCTION Non-Final OA GLAXOSMITHKLINE BIOLOGICALS S.A.
17907746 METHOD FOR QUANTIFYING MODIFIED HDL AND ANALYTICAL REAGENT USED THEREFOR Non-Final OA Tatsuya Sawamura
18240485 SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA Non-Final OA Follea International
18360627 CRYOPRESERVING UNGULATE EMBRYOS Non-Final OA ABS Global, Inc.
18041606 METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE Non-Final OA FORSCHUNGZENTRUM BORSTEL LEIBNIZ-LUNGENZENTRUM
16245063 SYSTEMS AND METHODS FOR ELECTROCHEMICAL CREATININE ASSAYS AND BLOOD UREA NITROGEN Final Rejection POLYMER TECHNOLOGY SYSTEMS, INC.
17637128 Cardiovascular Risk Event Prediction and Uses Thereof Non-Final OA SomaLogic Operating Co., Inc.
17606033 FORMULATIONS AND METHODS FOR DRUG INSTILLATION INTO THE BLADDER AND TREATMENT OF BLADDER AILMENTS Non-Final OA TRIGONE PHARMA LTD.
17427446 T CELL REPERTOIRE DYNAMICS AND ONCOLYTIC VIRAL THERAPY Non-Final OA Oncolytics Biotech Inc.
17282667 ARTIFICIAL HUMAN PULMONARY AIRWAY AND METHODS OF PREPARATION Non-Final OA Andrei GEORGESCU

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month